Blood Reviews
Volume 17, Issue 1 , Pages 7-14 , March 2003

Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management

  • Keith R McCrae

      Affiliations

    • Corresponding Author InformationCorrespondence to: Keith R. McCrae, M.D., Associate Professor of Medicine, Department of Medicine, Hematology-Oncology, BRB3, Case Western Reserve University and University Hospitals of Cleveland, 10900 Euclid Avenue, Cleveland, OH 44106-4937, USA. Tel.: 216-368-1175; Fax: 1-216-368-1166

References 

  1. Sainio S, Kekomäki R, Riikonon S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet. Gynaecol. Japonica. 2000;79:744–749
  2. Boehlen F, Hohlfeld H, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet. Gynecol. 2000;95:29–33
  3. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology Am. Soc. Hematol. Educ. Program. 2001;282–305
  4. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood. 1992;80:2697–2714
  5. McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Sem. Hematol. 1997;34:148–158
  6. McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J. Clin. Apheresis. 2001;16:202–209
  7. Crowther MA, Burrows RF, Ginsberg J, Kelton JG. Thrombocytopenia in pregnancy: diagnosis, pathogenesis and managment. Blood Rev. 1996;10:8–18
  8. Shehata N, Burrows RF, Kelton JG. Gestational thrombocytopenia. Clin. Obstet. Gynecol. 1999;42:327–334
  9. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N. Engl. J. Med. 1988;319:142–145
  10. Burrows RF, Kelton JG. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am. J. Obstet. Gynecol. 1990;162:731–734
  11. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N. Engl. J. Med. 1993;329:1463–1466
  12. Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Br. J. Haematol. 1996;95:21–36
  13. ACOG Committee on Practice Bulletins: ACOG Practice Bulletin: thrombocytopenia in pregnancy. Int. J. Gynaecol. Obstet. 1999;67;117–122
  14. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N. Engl. J. Med. 2002;346:13–995
  15. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Sem. Hematol. 2000;37:275–283
  16. Bell WR, Kickler TS. Thrombocytopenia in pregnancy. Rheum. Dis. Clin. North Am. 1997;23:183–191
  17. Lescale KB, Eddleman KA, Cines DB, Samuels P, Lesser ML, McFarland JG, et al. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am. J. Obstet. Gynecol. 1996;174:1014–1018
  18. Boehlen F, Hohlfeld P, Extermann P, de Moerloose P. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet. Gynecol. 1999;93:169–173
  19. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3–40
  20. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000/μl. Anesth. Analg. 1997;85:385–390
  21. Bussel JB. Splenectomy sparing strategies for the treatment and long term maintenance of chronic idiopathic immune thrombocytopenic purpura. Sem. Hematol. 2000;37:1–3
  22. Gottlieb P, Axelsson O, Bakos O, Rastad J. Splenectomy during pregnancy: an option in the treatment of autoimmune thrombocytopenic purpura. Br. J. Obstet. Gynaecol. 1999;106:373–375
  23. Anglin BV, Rutherford C, Ramus R, Lieser M, Jones DB. Immune thrombocytopenic purpura during pregnancy: Laparoscopic treatment. J. Soc. Laparosc. Surg. 2001;5:63–67
  24. Hardwick RH, Slade RR, Smith PA, Thompson MH. Laparoscopic splenectomy in pregnancy. J. Laparoendosc. Adv. Surg. Tech. 1999;9:439–440
  25. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum. Dis. Clin. North Am. 1997;23:149–167
  26. Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol. Ther. 1997;74:207–220
  27. Grsoo Z, Rodriguez JJ, Stalnaker BL. Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. J. Repro. Med. 1995;40:739–742
  28. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: Assessing the risks for the infant at delivery. Obstet. Gynecol. Surv. 1993;48:781–788
  29. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennutti MT, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N. Engl. J. Med. 1990;323:229–235
  30. Valat AS, Caulier MT, Devos P, Rugeri L, Wibaut B, Vaast P, et al. Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia. Br. J. Haematol. 1998;103:397–401
  31. Moise KJ, Cotton DB. Discordant fetal platelet counts in a twin gestation complicated by idiopathic thrombocytopenic purpura. Am. J. Obstet. Gynecol. 1987;156:1141–1142
  32. Godelieve C, Christiaens ML, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet. Gynecol. 1997;90:546–552
  33. Stamilio DM, Macones GA. Selection of delivery methods in pregnancies complicated by autoimmune thrombocytopenia: a decision analysis. Obstet. Gynecol. 2002;94:41–47
  34. Peleg D, Hunter SK. Perinatal management of women with immune thrombocytopenic purpura: survey of United States perinatologists. Am. J. Obstet. Gynecol. 1999;180:645–650
  35. Cook RL, Miller RC, Katz VL, Cefalo RC. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet. Gynecol. 1991;78:578–583
  36. Kahn DJ, Richardson DK, Billett HH. Association of thrombocytopenia and delivery method with intraventricular hemorrhage among very-low-birth-weight infants. Am. J. Obstet. Gynecol. 2002;186:109–116
  37. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. J. Am. Med. Assoc. 2002;287:3183–3186
  38. Moore JC, Hayward CPM, Warkentin TE, Kelton JG. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood. 2001;98:1842–1846
  39. Skjærven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N. Engl. J. Med. 2002;346:33–38
  40. Broughton Pipkin F, Roberts JM. Hypertension in pregnancy. Hum. Hypertens. 2000;14:705–723
  41. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 2001;344:867–872
  42. Kupferminc MJ, Eldor A, Steinman M, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 1999;340–349
  43. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur. J. Obstet. Gynecol. Repro. Biol. 2002;101:6–14
  44. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infants. Am. J. Obstet. Gynecol. 1987;157:360–363
  45. Goldman-Wohl D, Yagel S. Regulation of trophoblast invasion: From normal implantation to preeclampsia. Mol. Cell Endocrinol. 2002;187:233–238
  46. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J. Clin. Invest. 1993;91:950–960
  47. Graham CH, McCrae KR. Expression of gelatinase and plasminogen activator activity by trophoblast cells isolated from the placentae of normal and preeclamptic women. Am. J. Obstet. Gynecol. 1996;175:555–562
  48. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial cell growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes and low platelets syndrome. Am. J. Pathol. 2002;160:1405–1423
  49. Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta. 1991;12:301–308
  50. Schjetlein R, Haugen G, Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 1997;1997:76–541
  51. Tank PD, Nadanwar YS, Mayadeo NM. Outcome of pregnancy with severe liver disease. Int. J. Gynaecol. Obstet. 2002;76:27–31
  52. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am. J. Obstet Gynecol. 1990;162:311–316
  53. von Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long term follow-up of patients with a history of (H)ELLP syndrome. Hypertens. Pregenancy. 2001;20:15–23
  54. Baschat AA, Gembruch U, Reiss I, Gortner L, Weiner CP, Harman CR. Absent umbilical artery end-diastolic velocity in growth-restricted fetuses: a risk factor for neonatal thrombocytopenia. Obstet. Gynecol. 2000;76:234–239
  55. Burrows RF, Andrew M. Neonatal thrombocytopenia in the hypertensive disorders of pregnancy. Obstet. Gynecol. 1990;76:234–238
  56. Dame C. Thrombopoietin in thrombocytopenias of childhood. Sem. Thromb. Haemost. 2001;27:215–228
  57. Roberts IA, Murray NA. Neonatal thrombocytopenia: new insights into pathogenesis and implications for fetal management. Curr. Topics Micro. Immunol. 2001;13:16–23
  58. Watts TL, Murray NA, Roberts IAG. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Ped. Res. 1999;46:28–32
  59. Paul DA, Leef KH, McKenzie S. Thrombopoietin in preterm infants: gestational age dependent response. J. Ped. Hematol. Oncol. 2002;24:304–309
  60. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. National institute of child health and human development network of maternal-fetal medicine units: low dose aspirin to prevent preeclampsia in women at high risk. N. Engl. J. Med. 1998;338:701–705
  61. Collaborative Low Dose Aspirin Study in Pregnancy Collaborative Group: Clasp: a randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet. 1994;343:619–624
  62. Martin JN, Files JC, Blake PG, Perry KG, Morrison JC, Norman PH. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes and low platelets syndrome). Am. J. Obstet. Gynecol. 1995;172:1107–1112
  63. Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am. J. Obstet. Gynecol. 1997;177:1011–1017
  64. Esplin MS, Branch DW. Diagnosis and management of thrombotic microangiopathies during pregnancy. Clin. Obstet. Gynecol. 1999;42:360–368
  65. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 1998;339:1578–1584
  66. Tsai H-M, Lian ECY. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 1998;339:1585–1594
  67. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494
  68. Mannucci PM, Canciani T, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98:2730–2735
  69. Brostrom S, Bergmann OJ. Thrombotic thrombocytopenic purpura: A difficult differential diagnosis in pregnancy. Acta Obstet. Gynecol. Scand. 2000;79:84–89
  70. Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum period. Sem. Hematol. 1987;24:119–129
  71. Ezra Y, Rose M, Eldor A. Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. Am. J. Hematol. 1996;51:1–6
  72. Mokrzycki MH, Rickles FR, Kaplan AA, Kohn OF. Thrombotic thrombocytopenic purpura in pregnancy: successful treatment with plasma exchange. Blood Purif. 1995;13:271–274
  73. Dashe JS, Ramin SM, Cunningham FG. The long term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet. Gynecol. 1998;91:662–668
  74. Bacq Y. Acute fatty liver of pregnancy. Sem. Perinatol. 1998;22:134–140
  75. Ibdah JA, Yang Z, Bennett MJ. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol. Genet. Metab. 2000;71:182–187
  76. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N. Engl. J. Med. 1999;340:1723–1731
  77. Vigil-De Gracia P. Acute fatty liver and HELLP syndrome: Two distinct pregnancy disorders. Int. J. Gynaecol. Obstet. 2001;73:215–221
  78. Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Ann. Int. Med. 1977;86:220–229
  79. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arth. Rheum. 1999;42:1309–1311
  80. Campbell D, Parr MJA, Shutt LE. Unrecognized “crack” cocaine use in pregnancy. Br. J. Anesthesiol. 1996;77:553–555
  81. Kain ZN, Mayes LC, Pakes J, Rosenbaum SH, Schottenfeld R. Thrombocytopenia in pregnant women who use cocaine. Am. J. Obstet. Gynecol. 1995;173:885–890
  82. Altès A, Pujol-Moix N, Muñiz-Diaz E, Madoz P, Parra J, Fontcuberta J. Hereditary macrothrombocytopenia and pregnancy. Thromb. Haemost. 1996;76:29–33
  83. Pajor A, Nemes L, Demeter J. May Hegglin anomaly and pregnancy. Eur. J. Obstet. Gynecol. Repro. Biol. 1999;85:229–231
  84. Chiurazzi F, Villa MR, Rotoli B. Transplacental transmission of EDTA-dependent pseudothrombocytopenia. Haematologica. 1999;84:664–668
  85. Burlingame J, McGaraghan A, Kilpatrick S, Hambleton J, Main E, Laros RK. Maternal and fetal outcomes in pregnancies affected by von Willebrand disease type 2. Am. J. Obstet. Gynecol. 2001;184:229–230

PII: S0268-960X(02)00056-5

Blood Reviews
Volume 17, Issue 1 , Pages 7-14 , March 2003

Article Tools